1-20 of 88
Peter S. Nelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C033: Identifying and targeting prostate cancer therapy resistance mechanisms driven by the tumor microenvironment

Tony Lok Heng Chu, Armand Bankhead, Ilsa Coleman, Sander Frank, Peter S. Nelson, Tarana Arman
Journal: Cancer Research
Cancer Res (2024) 84 (22_Supplement): C033.
https://doi.org/10.1158/1538-7445.TUMBODY-C033
Published: 17 November 2024
View articletitled, Abstract C033: Identifying and targeting prostate cancer therapy resistance mechanisms driven by the tumor microenvironment
Journal Articles

Abstract 2754: Uncovering the role of TEADs in treatment induced small cell or neuroendocrine prostate cancer

Lisha G. Brown, Ilsa M. Coleman, Tony L. Chu, Daniel W. Lin, John K. Lee, Erolcan Sayar, Lawrence D. True, Ruth Dumpit, Eva Corey, Peter S. Nelson, Michael C. Haffner, Colm Morrissey
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2754.
https://doi.org/10.1158/1538-7445.AM2024-2754
Published: 22 March 2024
View articletitled, Abstract 2754: Uncovering the role of TEADs in treatment induced small cell or neuroendocrine prostate cancer
Journal Articles

Abstract 4302: ONECUT2 activates diverse resistance drivers of androgen receptor-independent heterogeneity in prostate cancer

Chen Qian, Qian Yang, Mirja Rotinen, Rongrong Huang, Hyoyoung Kim, Brad Gallent, Yiwu Yan, Radu M. Cadaneanu, Baohui Zhang, Salma Kaochar, Stephen J. Freedland, Edwin M. Posadas, Leigh Ellis, Dolores Di Vizio, Colm Morrissey, Peter S. Nelson, Lauren Brady, Ramachandran Murali, Moray J. Campbell, Wei Yang, Beatrice S. Knudsen, Elahe A. Mostaghel, Huihui Ye, Isla P. Garraway, Sungyong You, Michael R. Freeman
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4302.
https://doi.org/10.1158/1538-7445.AM2024-4302
Published: 22 March 2024
View articletitled, Abstract 4302: ONECUT2 activates diverse resistance drivers of androgen receptor-independent heterogeneity in prostate cancer
Journal Articles

Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Shiqin Liu, Sarah Hawley, Christian Kunder, En-Chi Hsu, Michelle Shen, Merve Aslan, Fernando J. Marques, Chung S. Lee, Abel Bermudez, Lennart Westphalen, Heidi Auman, Lisa F. Newcomb, Daniel W. Lin, Peter S. Nelson, Ziding Feng, Maria S. Tretiakova, Lawrence D. True, Funda Vakar-Lopez, Peter R. Carroll, Jeffry Simko, Martin E. Gleave, Dean A. Troyer, Jesse K. McKenney, Donna Peehl, Sharon J. Pitteri, James D. Brooks, Michael A. Liss, Tanya Stoyanova
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6962.
https://doi.org/10.1158/1538-7445.AM2024-6962
Published: 22 March 2024
View articletitled, Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer
Journal Articles

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

Michael D. Nyquist, Ilsa M. Coleman, Jared M. Lucas, Dapei Li, Brian Hanratty, Hannah Meade, Elahe A. Mostaghel, Stephen R. Plymate, Eva Corey, Michael C. Haffner, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2023) 83 (17): 2938–2951.
https://doi.org/10.1158/0008-5472.CAN-22-2613
Published: 01 September 2023
View articletitled, Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Open the PDF for Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex in another window
Includes: Supplementary data
Journal Articles

Abstract B004: Genomic loss of TP53 impairs AR-targeted activity in metastatic prostate cancer

Wanting Han, Michael D. Nyquist, Ilsa Coleman, Navonil De Sarkar, Lisa Ang, Eva Corey, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): B004.
https://doi.org/10.1158/1538-7445.PRCA2023-B004
Published: 02 June 2023
View articletitled, Abstract B004: Genomic loss of TP53 impairs AR-targeted activity in metastatic prostate cancer
Journal Articles

Abstract IA017: Anticipating, tracking, and targeting new prostate cancer lineages driven by treatment pressures

Peter S. Nelson
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): IA017.
https://doi.org/10.1158/1538-7445.PRCA2023-IA017
Published: 02 June 2023
View articletitled, Abstract IA017: Anticipating, tracking, and targeting new prostate cancer lineages driven by treatment pressures
Journal Articles

Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)

Lisa F. Newcomb, Yingye Zheng, Menghan Liu, James D. Brooks, Peter R. Carroll, Atreya Dash, William J. Ellis, Christopher J. Filson, Martin E. Gleave, Michael A. Liss, Frances M. Martin, Todd M. Morgan, Peter S. Nelson, Andrew A. Wagner, Daniel W. Lin
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): B048.
https://doi.org/10.1158/1538-7445.PRCA2023-B048
Published: 02 June 2023
View articletitled, Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)
Journal Articles

Abstract B020: BCL2 expression is enriched in AR-independent advanced prostate cancer

Daniel Westaby, Juan M. Jimenez-Vacas, Ines Figueiredo, Claire Pettinger, Bora Gurel, Denisa Bogdan, Jan Rekowski, Lorenzo Buroni, Antje Neeb, Ruth Riisnaes, Mateus Crespo, Susana Miranda, Ana Ferreira, Daniel Nava Rodrigues, George Seed, Claudia Bertan, Maria de los Dolores Fenor de la Maza, Christina Guo, Juliet Carmichael, Rafael Grochot, Khobe Chandran, Andreas Varkaris, Steven P. Balk, Wei Yuan, Suzanne Carreira, Peter S. Nelson, Michael Haffner, Eva Corey, Johann de Bono, Adam Sharp
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): B020.
https://doi.org/10.1158/1538-7445.PRCA2023-B020
Published: 02 June 2023
View articletitled, Abstract B020: BCL2 expression is enriched in AR-independent advanced prostate cancer
Journal Articles

Understanding Drug Sensitivity and Tackling Resistance in Cancer

Jeffrey W. Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B. Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J. Alumkal, Trever G. Bivona, Keith Syson Chan, Brian J. Druker, Alan D. Hutson, Peter S. Nelson, Charles L. Sawyers, Christopher D. Willey
Journal: Cancer Research
Cancer Res (2022) 82 (8): 1448–1460.
https://doi.org/10.1158/0008-5472.CAN-21-3695
Published: 15 April 2022
View articletitled, Understanding Drug Sensitivity and Tackling Resistance in Cancer
Open the PDF for Understanding Drug Sensitivity and Tackling Resistance in Cancer in another window
Journal Articles

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung-Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2021) 81 (18): 4736–4750.
https://doi.org/10.1158/0008-5472.CAN-21-0307
Published: 15 September 2021
View articletitled, RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer
Open the PDF for RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract LB022: Griffin: A method for nucleosome profiling and breast cancer subtype prediction from ultra-low pass whole genome sequencing of cell-free DNA

Anna-Lisa Doebley, Hanna Liao, Caroline Kikawa, Eden Cruikshank, Minjeong Ko, Anna Hoge, Joseph Hiatt, Navonil De Sarkar, Viktor A. Adalsteinsson, Paz Polak, David MacPherson, Peter S. Nelson, Heather A. Parsons, Daniel Stover, Gavin Ha
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB022.
https://doi.org/10.1158/1538-7445.AM2021-LB022
Published: 01 July 2021
View articletitled, Abstract LB022: Griffin: A method for nucleosome profiling and breast cancer subtype prediction from ultra-low pass whole genome sequencing of cell-free DNA
Journal Articles

Abstract 1458: Targeting fibroblast growth factor receptors in castration-resistant prostate cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Holly M. Nguyen, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1458.
https://doi.org/10.1158/1538-7445.AM2021-1458
Published: 01 July 2021
View articletitled, Abstract 1458: Targeting fibroblast growth factor receptors in castration-resistant prostate cancer
Journal Articles

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Shangze Li, Ka-wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu
Journal: Cancer Research
Cancer Res (2020) 80 (10): 2072.
https://doi.org/10.1158/0008-5472.CAN-20-0768
Published: 15 May 2020
View articletitled, Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Open the PDF for Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer in another window
Journal Articles

PEG10 Promoter–Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer

Mariya Shapovalova, John K. Lee, Yingming Li, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Scott M. Dehm, Aaron M. LeBeau
Journal: Cancer Research
Cancer Res (2019) 79 (21): 5668–5680.
https://doi.org/10.1158/0008-5472.CAN-19-2181
Published: 01 November 2019
View articletitled, PEG10 Promoter–Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer
Open the PDF for PEG10 Promoter–Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 2962: Targeting BCL2 as a therapeutic strategy in neuroendocrine prostate cancer

Alexandra N. Corella, Jared M. Lucas, Arja Kaipainen, Ilsa M. Coleman, Colm Morrissey, Eva Corey, Paul Nghiem, David MacPherson, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2962.
https://doi.org/10.1158/1538-7445.AM2019-2962
Published: 01 July 2019
View articletitled, Abstract 2962: Targeting BCL2 as a therapeutic strategy in neuroendocrine prostate cancer
Journal Articles

Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer

Jacob A. Gordon, Jake W. Noble, Ankur Midha, Fatemeh Derakhshan, Gang Wang, Hans H. Adomat, Emma S. Tomlinson Guns, Yen-Yi Lin, Shancheng Ren, Collin C. Collins, Peter S. Nelson, Colm Morrissey, Kishor M. Wasan, Michael E. Cox
Journal: Cancer Research
Cancer Res (2019) 79 (13): 3320–3331.
https://doi.org/10.1158/0008-5472.CAN-18-2529
Published: 01 July 2019
View articletitled, Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer
Open the PDF for Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Bryce Lakely, Lori Kollath, Daniel W. Lin, Lawrence D. True, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4392.
https://doi.org/10.1158/1538-7445.AM2019-4392
Published: 01 July 2019
View articletitled, Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer
Journal Articles

Abstract 379: Supraphysiological testosterone inhibits tumor growth and is associated with inhibition of ARV7 signaling and DNA damage response in preclinical models of enzalutamide-resistant prostate cancer

Hung-Ming Lam, Mark P. Labrecque, Holly M. Nguyen, Lisha G. Brown, Ilsa M. Coleman, Roman Gulati, Bryce Lakely, Daniel Sondheim, Brett Marck, Alvin M. Matsumoto, Elahe A. Mostaghel, Michael T. Schweizer, Peter S. Nelson, Eva Corey
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 379.
https://doi.org/10.1158/1538-7445.AM2019-379
Published: 01 July 2019
View articletitled, Abstract 379: Supraphysiological testosterone inhibits tumor growth and is associated with inhibition of ARV7 signaling and DNA damage response in preclinical models of enzalutamide-resistant prostate cancer
Journal Articles

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Shangze Li, Ka-wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu
Journal: Cancer Research
Cancer Res (2019) 79 (10): 2580–2592.
https://doi.org/10.1158/0008-5472.CAN-18-2812
Published: 15 May 2019
View articletitled, Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Open the PDF for Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer in another window
Includes: Supplementary data